[Asia Economy Reporter Gong Byung-sun] On the 3rd, the Korea Exchange KOSDAQ Market Division requested an inquiry disclosure from M2N regarding rumors of acquiring Myungmoon Pharmaceutical. On the same day, the Korea Exchange KOSPI Market Division also requested an inquiry disclosure from Myungmoon Pharmaceutical concerning rumors of the largest shareholder's stake sale.
The deadline for response is by 12:00 PM on the 4th.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![From Hostess to Organ Seller to High Society... The Grotesque Scam of a "Human Counterfeit" Shaking the Korean Psyche [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
